New Challenges in the Management of Heart Failure: Meet the Experts
This online clinical academic event will focus on recent advances in the management of heart failure. The event consists of two online sessions (webinar format) on consecutive days and approximately 2 hours in duration each. As the focus of the programme is on practical management of heart failure, the webinar sessions will be based on exemplary clinical cases and guideline recommendations to provide the attendees with up to date expert opinion on the different aspects of pharmacological treatment of heart failure.
All Faculty members are experts of international calibre with extensive clinical and research networks worldwide. Most of them have contributed to the development of national and international management guidelines.
This webinar is supported by:
12:00 - 12:10
Welcome and introduction-Juan Carlos Kaski
12:10 - 12:35
Diabetes and HF - Clinical impact of new oral antidiabetic agents. -Ramzi Ajjan
12:35 - 13:00
Iron deficiency, frailty, clinical outcomes and management. -Theresa McDonagh
13:00 - 13:25
How to manage cardio-renal issues in HF. -Debasish Banerjee
13:25 - 14:00
MDT Case Presentations - Managing HF in patients with diabetes and CKD -ALL
- To gain insight into the most recent developments in the pathophysiology of different forms of heart failure, including HFpEF and HFrEF.
- To briefly discuss non-cardiac treatments affecting heart function i.e. oncological treatments.
- To discuss current international management guidelines and their application to specific cases.
- To gain insight into the management of heart failure patients affected by different co-morbidities such as diabetes and chronic kidney disease.
- To present and discuss the management of iron deficiency and frailty in heart failure.
- The webinar is aimed at cardiac consultants, diabetologists, vascular surgeons, renal physicians, general practitioners with an interest in cardiovascular disease, specialist nurses and other health professionals involved in heart failure, cardiovascular
Juan Carlos Kaski
Juan Carlos Kaski is Professor of Cardiovascular Science (Emeritus) at the Molecular and Clinical Sciences Research Institute, St Gorge’s, University of London, and Hon. Consultant Cardiologist at St George’s Hospital and the Royal Brompton Hospital in London, UK. He is Doctor Honoris Causa of several universities worldwide, a past-President of the International Society of Cardiovascular Pharmacotherapy and Fellow of over 30 scientific societies worldwide. JC Kaski has received numerous national and international awards for his research work and both his clinical and educational activities. Professor Kaski is Chairman-elect, European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy, Editor-in-Chief of the European Cardiology Review Journal, Deputy Editor of the European Heart Journal, Co-Editor of the ESC Handbook on Cardiovascular Pharmacotherapy and editorial board member of JACC and over 20 other scientific journals. Prof Kaski’s research areas include inflammatory and immunological mechanisms of atherosclerosis, microvascular and vasospastic angina, INOCA and MINOCA, biomarkers of cardiovascular risk and management of angina pectoris. He has authored over 600 scientific papers on these topics in peer review journals and edited 10 books.
Professor Juan Carlos Kaski is Editor-In-Chief of the European Cardiology Review.
Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London where he is also the director of MSc Heart Failure.
After obtaining his MD in Medicine and Surgery at the La Sapienza University of Rome, Prof Rosano obtained his specialisation in cardiology from the same University before attaining his PhD in Medical Sciences from Imperial College London. His research interests focus on experimental and clinical pharmacology, heart failure, cardiac metabolism, diabetes and gender differences in cardiovascular diseases.
Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian Drug Agency. He is the President-Elect of the Heart Failure Association Board (HFA), and Chairman of the Education Committee of the HFA. Prof Rosano is on the editorial board for European Journal of Heart Failure, European Heart Journal CV Pharmacotherapy, Cardiac Failure Reviews and Cardiovascular Diabetology. He has authored more than 500 peer-reviewed articles, eight books and 32 book chapters.
Dr Giuseppe Rosano is Deputy Editor-in-Chief of Cardiac Failure Review.
Theresa A McDonagh
Theresa McDonagh is a consultant cardiologist at King's College London. Her research interests are in clinical heart failure, in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers. Prof McDonagh is currently chair of the Clinical Section of the Heart Failure Association of the ESC and clinical lead for the National Heart Failure Audit.
Dr Theresa McDonagh is an Editorial Board member of Cardiac Failure Review.
Debasish Banerjee is a consultant nephrologist with special interest in cardiovascular complications of chronic kidney disease including heart failure, sudden cardiac death and cardiac workup before kidney transplantation in chronic kidney disease patients; glomerulonephritis, kidney stone disease and diabetic nephropathy.
He serves as the Clinical Subdean for St Georges Hospital and Higher Education Academic Director for St Georges, University of London.
His research interest is cardiac and vascular changes in chronic kidney disease with impact of vitamin D and kidney transplantation. He has received several research grants from British Heart Foundation, National Institute of Healthcare Research, British Renal Society, Guys & St. Thomas’ Charity and St. Georges’ Charity.
He is the centre director for the International Society of Nephrology Renal Sister Centre program fostering collaboration in research and education.
Dr Debasish Banerjee is on the Editorial Board of European Cardiology Review.
Dr Robin Ray graduated from Oxford University and Guy’s, King’s and St Thomas’ School of Medicine, London. He was received a BHF scholar award and a BHF clinical PhD studentship and completed a PhD at King’s College Hospital, London in endothelial function, blood pressure and heart failure. He trained on the South East London Cardiology rotation and completed a cardiac imaging fellowship at the Brompton Hospital. He was appointed Consultant Cardiologist in January 2015 at St George’s University Hospitals NHS Foundation Trust in London. He was appointed Head of Education in September 2015.
Dr Robin Ray is on the Editorial Board of European Cardiology Review.
Prof Ajjan is a Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. He runs a programme of basic, translational and clinical research studies with the collective aim of reducing vascular complications and improving quality of life in individuals with diabetes. His clinical studies have focussed on optimising glycaemic control by reducing high glucose levels while avoiding hypoglycaemia and keeping glucose variability to a minimum. His translational work aims to uncover novel therapeutic targets to reduce the prothrombotic environment in diabetes, a key abnormality in this condition. He has over 150 publications including original articles, reviews and book chapters. His clinical practice concentrates on young adults with diabetes and older individuals at high risk of vascular disease.
He is local R&D lead for Diabetes/Endocrinology and regional clinical research network co-lead for diabetes, endocrine and metabolic conditions. He is deputy Chair of the Clinical Study Group 2 at Diabetes UK, Associate Editor of Diabetes and Vascular Disease Research and member of the editorial board of International Journal of Molecular Sciences.
1. Cubbon RM, Adams B, Rajwani A, et al. Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology. Diab Vasc Dis Res. 2013;10(4):330-336.
2. Lehrke M, Marx N. Diabetes Mellitus and Heart Failure. Am J Cardiol. 2017;120(1S):S37-S47.
3. McDonagh T, Damy T, Doehner W, et al. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018;20(12):1664-1672.
4. Jenkins R, Mandarano L, Gugathas S, Kaski JC, Anderson L, Banerjee D. Impaired renal function affects clinical outcomes and management of patients with heart failure. ESC Heart Fail. 2017;4(4):576-584
5. Nguyen M, Rumjaun S, Lowe-Jones R, et al. Management and outcomes of heart failure patients with CKD: experience from an inter-disciplinary clinic [published online ahead of print, 2020 Jul 11]. ESC Heart Fail. 2020;10.1002